January 2, 2026 · Form 4 insider transaction
STEELE GLENN JR MD PHD bought 12,000 shares of PTC Therapeutics Inc at $30.86 per share, a transaction worth $370.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 8, 2025.